Remedy (REMEDY.HE) Stock Analysis & AI Equity Report

Information Technology EUR Explore free reports

Remedy (REMEDY.HE) overview

Remedy (REMEDY.HE) stock analysis and AI equity research. For the latest completed financial year, 2025, Remedy reported revenue of EUR 59.5m and operating profit of EUR -4.3m; the year-end share price was 15.20 EUR and market capitalisation was EUR 207m. Remedy is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Remedy's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueEUR 56.6mFY 2025
Share price15.20 EURFY 2025 year end
RevenueEUR 59.5mFY 2025
Operating profitEUR -4.3mFY 2025
Net earningsEUR -13.0mFY 2025
Market capitalisationEUR 207mFY 2025 year end

Figures updated on 2026-07-27. Data will be refreshed during report generation.

About Remedy

Remedy Entertainment is a Finnish video game company that develops story-driven action games for PC and consoles. Its portfolio includes the Control and Alan Wake franchises, and it also builds the proprietary Northlight engine and related tools. The company works with publishing and co-development partners and is moving toward self-publishing selected owned games.

Generate the Remedy report

Remedy is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, typically within about 30 minutes

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Remedy and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Remedy

Each is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by what other analysts said the work added over the engine's report — a score out of five from people who had to read it to give it.